The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

• Main Authors: Young Jun Ko (Author), Young Kyu Shim (Author), Woo Joong Kim (Author), Soo Yeon Kim (Author), Hunmin Kim (Author), Hee Hwang (Author), Jong-Hee Chae (Author), Ji Eun Choi (Author), Ki Joong Kim (Author), Byung Chan Lim (Author)
• Format: Book
• Published: Korean Child Neurology Society, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory disorders to improve clinical outcomes in cases refractory to conventional immunotherapy and to reduce relapses. This study aimed to demonstrate the efficacy and safety of rituximab used for pediatric autoimmune n...